Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease

AIMS: Coronavirus disease 2019 (COVID‐19) is a widespread pandemic with an increased morbidity and mortality, especially for patients with cardiovascular diseases. Angiotensin‐converting enzyme 2 (ACE2) has been identified as necessary cell entry point for SARS‐CoV‐2. Previous animal studies have de...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebek, Simon, Tafelmeier, Maria, Messmann, Rebecca, Provaznik, Zdenek, Schmid, Christof, Maier, Lars S., Birner, Christoph, Arzt, Michael, Wagner, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675329/
https://www.ncbi.nlm.nih.gov/pubmed/33017071
http://dx.doi.org/10.1002/ejhf.2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675329/
https://www.ncbi.nlm.nih.gov/pubmed/33017071
http://dx.doi.org/10.1002/ejhf.2020

Ejemplares similares